1. Next-Generation Vaccine Delivery Technologies

Session Chair: Giuseppe Bardi, Istituto Italiano di Tecnologia, Italy

3. Vaccine Research & Development

Session Chair: Birger Trollfors, Sahlgrenska University Hospital, Sweden

 

5. Vaccination Strategies

(2-1). Pulse vaccination strategy
(2-2). Ring vaccination
(2-3). Cocooning (immunization)

7. Bacterial Diseases

(4-1). Caries vaccine
(4-2). Ehrlichiosis vaccine
(4-3). Leprosy vaccine
(4-4). Lyme disease vaccine
(4-5). Staphylococcus aureus vaccine
(4-6). Streptococcus pyogenes vaccine
(4-7). Syphilis vaccine
(4-8). Tularemia vaccine
(4-9). Yersinia pestis vaccine

9. Non-infectious Diseases

(6-1). Alzheimer's disease amyloid protein vaccine
(6-2). Breast cancer vaccine
(6-3). Ovarian cancer vaccine
(6-4). Prostate cancer vaccine

11. Therapeutic Vaccines

(17-1).Therapeutic Cancer Vaccines
(17-1.1). Targeted Antigens
(17-1.2). Therapeutic Vaccine Strategies
(17-1.3). Therapeutic Vaccines in the Era of Combination Strategies
(17-2).Therapeutic Cancer Vaccines and Antiangiogenic Treatments Combinations
(17-2.1). Rationale for Vaccine Combination With AATs
(17-2.2). Preclinical Studies Combining AATs And Vaccines
(17-2.3). Clinical Trials Combining AATs And Vaccines
(17-3). Therapeutic Cancer Vaccines and Immune Checkpoint Blockade Combinations
(17-3.1). Rationale for Vaccine Combination With ICB
(17-3.2). Preclinical Studies Combining ICB And Vaccines
(17-3.3). Clinical Trials Combining ICB And Vaccines

13. Vaccines for Vector-borne Diseases

Session Chair: Will be updated soon...

15. Protein Based Vaccines

Session Chair: Will be updated soon...

17. Childhood Infection Vaccines

Session Chair: Will be updated soon...

2. Vaccines Policy and Regulatory Affairs

Session Chair: Kevin Galalae, Center of Global Consciousness, Canada

4. Viral Diseases

(1-1). Adenovirus vaccine
(1-2). Coxsackie B virus vaccine
(1-3). Cytomegalovirus vaccine
(1-4). Chikungunya vaccine
(1-5). Dengue vaccine for humans
(1-6). Eastern Equine encephalitis virus vaccine for humans
(1-7). Ebola vaccine
(1-8). Enterovirus 71 vaccine
(1-9). Epstein–Barr vaccine
(1-10). Hepatitis C vaccine
(1-11). HIV vaccine
(1-12). HTLV-1 T-lymphotropic leukemia vaccine for humans
(1-13). Marburg virus disease vaccine

6. Vaccines Safety, Efficacy & Clinical Trails

(3-1). Adverse effect (medicine)
(3-2). Adverse drug reaction
(3-3). Artificial induction of immunity
(3-4). Eczema vacinatum
(3-5). Norovirus vaccine
(3-6). Respiratory syncytial virus vaccine for humans
(3-7). Severe acute respiratory syndrome (SARS) vaccine
(3-8). West Nile virus vaccine for humans
(3-9). Zika fever

8. Parasitic Diseases

(5-1). Malaria vaccine
(5-2). Schistosomiasis vaccine
(5-3). Chagas disease vaccine
(5-4). Hookworm vaccine
(5-5). Onchocerciasis river blindness vaccine for humans
(5-6). Trypanosomiasis vaccine
(5-7). Visceral leishmaniasis vaccine

10. Human Vaccines

(9-1). Hepatitis Vaccines
(9-2). Mucosal Vaccines
(9-3). DNA Vaccines
(9-4). Tuberculosis Vaccines

12. Vaccine Immunology

(11-1). Immune responses to vaccines
(11-2). Immunology mechanisms
(11-3). Immunopathogenesis
(11-4). Immunity to infection
(11-5). Classical immunology
(11-6). Clinical immunology
(11-7). Computational immunology
(11-8). Diagnostic immunology
(11-9). Evolutionary immunology
(11-10). Immunotherapy
(11-11). Systems immunology
(11-12). Cancer immunology

14. Veterinary Vaccines

Session Chair: Will be updated soon...

16. Vaccines Business Development

Session Chair: Will be updated soon...

Watsapp